Figure 3 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
<p>Prevalence of extended therapy among patients who finished 5-year adjuvant hormone therapy, by whether recommended to extend therapy by the Swedish National Clinical Guideline, 2010 to 2020. Note: 365 of 504 patients who met the criteria to extend adjuvant hormone therapy in the clinical gu...
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | , , , |
| 出版: |
2025
|
| 主題: | |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|